chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Pain, Pain in extremity
Clinical narrative: Body aches; Fever; Chills; Sore arm; Diarrhoea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's thyroiditis. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN), both from an unknown dates for an unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 04Mar2021 at 16:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 11:00 after the second dose of vaccination, the patient experienced fever, chills, body aches, sore arm, diarrhea and headache. The patient did not receive any treatment for the reported events. The clinical outcome of the events of fever, chills, general body pain, pain in arm, diarrhea and headache was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; Fever; Chills; Sore arm; Diarrhoea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's thyroiditis. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN), both from an unknown dates for an unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 04Mar2021 at 16:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 11:00 after the second dose of vaccination, the patient experienced fever, chills, body aches, sore arm, diarrhea and headache. The patient did not receive any treatment for the reported events. The clinical outcome of the events of fever, chills, general body pain, pain in arm, diarrhea and headache was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Ocular hyperaemia, Pruritus, Rash, Rash erythematous
Clinical narrative: rash, from knuckles to wrists on the back of both hand; little blister; red; very itchy; redness/rashlike around both eyes (but no blisters) --looked kind of raccoon-like; started 3 days after 2nd vaccine,  still going a week later, although starting to dissipate; started using topical benadryl a couple days after it began; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: ep7534), via an unspecified route of administration in the left arm on 25Mar2021 at 17:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included mild eczema; the patient reported that the area around the eyes was prone to redness; on the hands though, it usually hit the knuckles. The patient never had it on the back of hands or wrists like this and it was never blistery. The patient said that she held off another 3 days before using a steroid cream, as she understood that steroids should be avoided for 2 weeks after second vaccination. The patient had known seasonal allergies; suspected nut and coconut sensitivities. Concomitant medications included Fexofenadine hydrochloride (Allegra) and amp, and vitamin D. The patient previously received her first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: en6202), via an unspecified route of administration in the left arm on 04Mar2021 at 05:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 28Mar2021, three days after the second dose of the vaccination, the patient experienced rash, from knuckles to wrists on the back of both hands - little blisters, red, very itchy; redness/rash like around both eyes (but no blisters)- looked kind of raccoon-like; started, still going a week later, although starting to dissipate. As a therapeutic measure, the patient started using topical benadryl a couple of days after the events began and later switched to benadryl tablets on 04April2021. The clinical outcome of the events was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Paraesthesia
Clinical narrative: Tightening/contracting pressure at the top of head as though someone was wrapping a band around head/ Each day since, I have experienced a strange pressure/moving sensation through out my head and into the right side of my neck,; Periodic ringing in lips and left side of jaw.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 31Mar2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) started on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 10Mar2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient previously took oxycodone and acetaminophen (PERCOCET) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 14:30, approximately 5 hours after vaccination, the patient experienced tightening/contracting pressure at the top of her head as though someone was wrapping a band around her head. Each day since, she had experienced a strange pressure/moving sensation throughout her head and into the right side of her neck, along with periodic ringing in her lips and the left side of her jaw. It was not reported whether the events resulted in a doctor or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the event tightening/contracting pressure at the top of the head as though someone was wrapping a band around the head was unknown, strange pressure/moving sensation throughout the head and into the right side of the neck and periodic ringing in lips and left side of the jaw was unknown at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the arm right on 01Apr2021 at 15:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN). The patient previously took flu shot and experienced minor outbreak of hives on his hands in 2016-17. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00, after 2685 minutes of the vaccination, the patient experienced swollen lymph nodes. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event swollen lymph nodes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Injection site pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 08:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, peanut allergy, potato allergy and food allergy (bell peppers). Concomitant medications included sertraline hydrochloride (ZOLOFT) and one a day woman's multi vitamin, both since an unknown date for an unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 09:00 the patient experienced Injection site pain and headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event Injection site pain and headache was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Hyperhidrosis, Pyrexia
Clinical narrative: Horrible Dizziness; Sweats; Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 15:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid removed, obesity, asthma, autoimmune disorder, COVID-19 and allergy to ACE inhibitors. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE) 175 mcg tablet and hydrochlorothiazide, triamterene (TRIAMTERENE HCTZ), both taken from unknown dates . Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced horrible dizziness, sweats, fever and fatigue. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events  horrible dizziness, sweats, fever and fatigue was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Colonoscopy, Computerised tomogram
Clinical narrative: Abdominal pain; This is a spontaneous report from a non-contactable consumer, the patient.  A 45-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in left arm on 20Mar2021 at 14:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced abdominal pain. On the same day, the patient underwent Computed Tomography (CT) scan and colonoscopy and the result was clean for both the tests. The adverse events result in a visit to the doctors or other healthcare professional office/clinic visit. The clinical outcome of the event abdominal pain was resolving at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Mass, Pain, Pyrexia, Sleep disorder
Clinical narrative: lump that looks like the top third of a small egg, on the clavicle; closer to the joint than to neck. It felt like bone. No pain. It seemed to "spread out." Wider, but not as defined; Aches after movement, such as going for a walk or vacuuming; right lymph node in my neck was tender; scratchy throat; slept on-and-off for most of the day; following the second vaccine I ran alow grade fever the following day.; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 17Mar2021(at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease stage 3 from an unspecified date. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 24Feb2021 at 16:15 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 18Mar2021 the patient experienced low grade fever. On 20Mar2021 at 06:00 the patient experienced mass, ache, lymph node tenderness, itchy throat, sleep disturbance. It was reported that third morning following second vaccine, the patient woke up with a lump, that looked like the top third of a small egg, on her clavicle; closer to the joint than to her neck. It felt like bone. No pain. It seemed to "spread out." Wider, but not as defined. The past few days it was back with a vengeance. Aches after movement, such as going for a walk or vacuuming. Also, following the second vaccine she ran a low-grade fever the following day, her right lymph node in her neck was tender and she had a scratchy throat. As it progressed, it felt as if her throat was closing, and then it disappeared just about the time she was getting concerned. She had slept on-and-off for most of the day. The next day she was fine, but still had the bump. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events mass, ache, lymph node tenderness, itchy throat, sleep disturbance, low grade fever was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: lump that looks like the top third of a small egg, on the clavicle; closer to the joint than to neck. It felt like bone. No pain. It seemed to "spread out." Wider, but not as defined; Aches after movement, such as going for a walk or vacuuming; right lymph node in my neck was tender; scratchy throat; slept on-and-off for most of the day; following the second vaccine I ran alow grade fever the following day.; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 17Mar2021(at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease stage 3 from an unspecified date. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 24Feb2021 at 16:15 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 18Mar2021 the patient experienced low grade fever. On 20Mar2021 at 06:00 the patient experienced mass, ache, lymph node tenderness, itchy throat, sleep disturbance. It was reported that third morning following second vaccine, the patient woke up with a lump, that looked like the top third of a small egg, on her clavicle; closer to the joint than to her neck. It felt like bone. No pain. It seemed to "spread out." Wider, but not as defined. The past few days it was back with a vengeance. Aches after movement, such as going for a walk or vacuuming. Also, following the second vaccine she ran a low-grade fever the following day, her right lymph node in her neck was tender and she had a scratchy throat. As it progressed, it felt as if her throat was closing, and then it disappeared just about the time she was getting concerned. She had slept on-and-off for most of the day. The next day she was fine, but still had the bump. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events mass, ache, lymph node tenderness, itchy throat, sleep disturbance, low grade fever was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ear infection, Head discomfort, Paranasal sinus discomfort, SARS-CoV-2 test
Clinical narrative: head pressure built up; sinus pressure built up; Double ear infection; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and pravastatin (MANUFACTURER UNKNOWN) on an unknown date, for unknown indication. The patient had no allergies to medications, food, or other products.  The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021 at 18:00, the patient experienced head pressure, sinus pressure and double ear infection. The patient reported that she had congestion began 6 hours after first dose, head and sinus pressure built up on next two days and she went to urgent care, COVID tests were performed and were negative she continued to worsen, so the patient went back to urgent care and was diagnosed with double ear infection. On 18Mar2021, the patient had COVID-19 virus test and result was found to be negative. Therapeutic measures were taken as a result of head pressure, sinus pressure and double ear infection and included treatment with azithromycin. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events head pressure, sinus pressure and double ear infection were recovered on an unknown date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Vaccination site pain
Clinical narrative: Injection site soreness; Full arm soreness; Generalized fatigue; This is a spontaneous report from a contactable consumer. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 01896589) via an unspecified route of administration in the arm left on 31Mar2021 at 11:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included Arthritis in both knees and allergic to purex laundry detergent. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Mar2021 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 15:30, the patient experienced injection site soreness, full arm soreness and generalized fatigue. The patient did not receive any treatment for the events. The clinical outcome of the events injection site soreness, full arm soreness and generalized fatigue was resolved on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Nerve compression, Pain in extremity
Clinical narrative: Nerve its pinched; I cannot perform some movements with my left arm; Pain in my left arm/pain in fingers; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in left arm on 19Mar2021 at 08:15 (at the age of 34 years) as single dose for COVID-19 immunisation. Medical history included thoracic-lumbar scoliosis. The patient had known allergies to lactose intolerant. Concomitant medication included cholecalciferol (Vitamin D3) (MANUFACTURER UNKNOWN), Probiotic 10 Nature Bounty (MANUFACTURER UNKNOWN) all from an unknown date, for unknown indication received within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021 at 08:15, patient experienced pain in left arm (pain in the whole arm) although it had been 17 days since the day of the vaccine, patient cannot perform some movements with left arm (for instance rotating the arm towards as if patient want to check the time on her watch), feels like nerve is pinched and even pain in fingers. No therapeutic measures were taken as a result of reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event patient experienced pain in left arm/ pain in fingers, cannot perform movements with left arm, nerve was pinched were not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling cold, Pain, Pain in extremity
Clinical narrative: Leg cramps/pain from knees down to palm of both feet.; Pain in muscle, bone and nerve; Tingling at bottom of feet; Feet were cold could not warm them; Small pain in arms; Fatigue; Joint pain; This is a spontaneous report from a contactable consumer, the patient,  A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EP9655) via an unspecified route of administration in the arm left on 30Mar2021 at 19:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease or hypothyroidism and food allergy (gluten and soy). Concomitant medications included nitrofurantoin (MANUFACTURER UNKNOWN) started from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 00:00, the patient experienced leg cramps/pain from knees down to palm of both feet, pain in muscle, bone and nerve, tingling at bottom of feet, feet cold could not warm, small pain in arms, fatigue and joint pain. The patient has reported that ER dr. cleared him of deep vein thrombosis, could feel small pangs in my arms, turned into fatigue and joint pain and then after 4 days it has gone at the time of reporting. It was  started after 72 hours. The event resulted in emergency room/department or urgent care. It was unknown whether the patient had received any treatment for the reported events. The clinical outcome of the event pain in legs, pain, feeling cold, pain in extremity, paresthesia, fatigue and joint pains was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Leg cramps/pain from knees down to palm of both feet.; Pain in muscle, bone and nerve; Tingling at bottom of feet; Feet were cold could not warm them; Small pain in arms; Fatigue; Joint pain; This is a spontaneous report from a contactable consumer, the patient,  A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EP9655) via an unspecified route of administration in the arm left on 30Mar2021 at 19:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease or hypothyroidism and food allergy (gluten and soy). Concomitant medications included nitrofurantoin (MANUFACTURER UNKNOWN) started from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 00:00, the patient experienced leg cramps/pain from knees down to palm of both feet, pain in muscle, bone and nerve, tingling at bottom of feet, feet cold could not warm, small pain in arms, fatigue and joint pain. The patient has reported that ER dr. cleared him of deep vein thrombosis, could feel small pangs in my arms, turned into fatigue and joint pain and then after 4 days it has gone at the time of reporting. It was  started after 72 hours. The event resulted in emergency room/department or urgent care. It was unknown whether the patient had received any treatment for the reported events. The clinical outcome of the event pain in legs, pain, feeling cold, pain in extremity, paresthesia, fatigue and joint pains was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Therapeutic product effect decreased, Withdrawal syndrome
Clinical narrative: BHRT Symptoms returned early; Arthritis, fibromyalgia and other painmeds stopped working.; Pain in arm; This is a spontaneous report from a contactable consumer, the patient . A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the right arm on 18Mar2021 at 13:30 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included menopause, arthritis, fibromyalgia, endometriosis, LS, injuries, pinched nerve, lactose intolerant and gluten sensitivity. Concomitant medications included Bioidentical Hormone Replacement Therapy (BHRT)(MANUFACTURER UNKNOWN), celecoxib (MANUFACTURER UNKNOWN), nortriptyline hydrochloride (NORTRIPTYLIN), metoprolol (MANUFACTURER UNKNOWN) and rabeparzole sodium (ACIPHEX), all taken from unknown dates for unknown indications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021, the patient experienced BHRT symptoms which returned early and arthritis, fibromyalgia and other pain medications had stopped working. On an unknown date in 2021, the patient experienced pain in arm on the third week prior to the second shot. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events BHRT symptoms returned early, arthritis, fibromyalgia and other pain medications had stopped working and pain in arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: Vertigo; Tinnitus located in one ear; This is a spontaneous report from a contactable other healthcare professional, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Feb2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 06Jan2021 at 09:30 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 26Feb2021 at 07:00, the patient experienced vertigo and tinnitus located in one ear. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events vertigo and tinnitus located in one ear were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Feeling abnormal, Hypoaesthesia
Clinical narrative: face started feeling weird/numb; face started feeling weird/numb; Swallowing felt strange; started to feel dizzy; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er 8734) via an unspecified route of administration in the left arm on 03Apr2021 at 19:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), and Hypermobile type Ehlers-Danlos syndrome (hEDS). The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received vicodin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 at 19:30, the patient waited 15 minutes felt fine, when driving home face started feeling weird and numb and swallowing felt strange. She pulled over because she started to feel dizzy. Her husband came and picked up, went to hospital in case of further reaction. The events resulted in emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events face started feeling weird and numb, swallowing felt strange and started to feel dizzy was recovered on unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Fatigue, Malaise
Clinical narrative: Injection site pain; Fatigue; Joint pain; Chills; Feeling sick; Lack of appetite; This is a spontaneous report from a contactable nurse, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 15Mar2021 at 15:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid nodule and sulfonamide allergy. Concomitant medications included acetylsalicylic acid (ASA) 41328 (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced injection site pain, fatigue, joint pain, chills, feeling sick and lack of appetite. The patient did not receive any treatment for the events.  The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events injection site pain, fatigue, joint pain, chills, feeling sick and lack of appetite was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; Fatigue; Joint pain; Chills; Feeling sick; Lack of appetite; This is a spontaneous report from a contactable nurse, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 15Mar2021 at 15:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid nodule and sulfonamide allergy. Concomitant medications included acetylsalicylic acid (ASA) 41328 (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced injection site pain, fatigue, joint pain, chills, feeling sick and lack of appetite. The patient did not receive any treatment for the events.  The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events injection site pain, fatigue, joint pain, chills, feeling sick and lack of appetite was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint stiffness, Migraine, Musculoskeletal stiffness, Myalgia
Clinical narrative: Migraine; joint pain; muscle pain; body ache; joint stiffness; muscle stiffness; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroidectomy, asthma, atrial fibrillation and tomato allergy from an unspecified date. Concomitant medications included gabapentin (MANAFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN methocarbamol (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took INDOCIN, TAGAMATE, ALEVE, phenobarbital (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00 the patient experienced migraine, joint pain, muscle pain, general body pain, joint stiffness, muscle stiffness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events migraine, joint pain, muscle pain, general body pain, joint stiffness, muscle stiffness was resolving at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Migraine; joint pain; muscle pain; body ache; joint stiffness; muscle stiffness; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroidectomy, asthma, atrial fibrillation and tomato allergy from an unspecified date. Concomitant medications included gabapentin (MANAFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN methocarbamol (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took INDOCIN, TAGAMATE, ALEVE, phenobarbital (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00 the patient experienced migraine, joint pain, muscle pain, general body pain, joint stiffness, muscle stiffness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events migraine, joint pain, muscle pain, general body pain, joint stiffness, muscle stiffness was resolving at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pain, Paraesthesia, Paraesthesia oral
Clinical narrative: Left arm, left leg, left groin, left side of neck , face and chin tingling/ pins and needles; lips and under tongue tingling; Neck felt like it was on fire; Painful; This is a spontaneous report from a contactable nurse. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 12Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to shellfish and avocado. Concomitant medications include prenatal medication, birth control medication, plantago ovata (METAMUCIL), ibuprofen (MOTRIN) and paracetamol (TYLENOL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, 30 mins after the vaccine the patient felt left arm, left leg, left groin, left side of neck and the face tingling. Then 45 mins after the vaccine the patient's neck felt like it was on fire. It was reported that the last 24 days (at the time of this report) the patient still had burning, tingling in neck, face, chin, lips and under tongue in mouth. It happened almost every day sometimes twice a day and felt like painful, burns and also felt like pins and needles. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events left arm, left leg, left groin, left side of neck, face, chin, lips and under tongue was tingling, felt like pins and needles, neck felt like it was on fire and painful was recovered with sequelae on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Lymphadenopathy, Muscle spasms
Clinical narrative: Severe stomach pain; Swollen glands; Vomiting; Severe headache; Severe fatigue; Knot in arm; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. It was unknown whether the patient had any allergies to medications, food, or other products. Concomitant medications included ziprasidone (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, right after second dose, the patient experienced sore arm and knot in arm (muscle spasm). On 28Mar2021 at 20:00, two days after second dose, the patient experienced severe fatigue and severe headache. On 02Apr2021, one week after second dose, the patient experienced vomiting, severe stomach pain, swollen glands and severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the event sore arm, knot in arm (muscle spasm), severe fatigue, severe headache, vomiting, severe stomach pain and swollen glands was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: Severe stomach pain; Swollen glands; Vomiting; Severe headache; Severe fatigue; Knot in arm; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. It was unknown whether the patient had any allergies to medications, food, or other products. Concomitant medications included ziprasidone (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, right after second dose, the patient experienced sore arm and knot in arm (muscle spasm). On 28Mar2021 at 20:00, two days after second dose, the patient experienced severe fatigue and severe headache. On 02Apr2021, one week after second dose, the patient experienced vomiting, severe stomach pain, swollen glands and severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the event sore arm, knot in arm (muscle spasm), severe fatigue, severe headache, vomiting, severe stomach pain and swollen glands was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.